+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

Visiongain Publishes Powered Surgical Instruments Market Report 2020-2030

30 July 2020
Pharma

Visiongain has launched a new report Powered Surgical Instruments Market Report 2020-2030: Forecasts by Power Source (Electric Instruments, Battery-powered Instruments, Pneumatic Instruments), Product (Handpieces, Power Source and Controls, Accessories), Application (Orthopedic Surgery, Oral and Maxillofacial Surgery, ENT Surgery, Neurosurgery, Plastic and Reconstructive Surgery, Cardiothoracic Surgery), and by Region (North America, Europe, Asia Pacific, Latin America & MEA), Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies.

Powered surgical instruments are used for surgical procedures for various purposes such as sculpting and precision drilling. These instruments can be powered using different sources such as electrical, pneumatic, and battery. The advancement in robotic surgeries will help to increase the demand for powered surgical instruments in the near future. Handpiece instruments is the largest contributor towards the powered surgical instruments market owing to the favourable features such as ease of use, better efficiency and power, and lightweight frames. Powered surgical instruments are commonly used for orthopaedic surgical procedures owing to the rise in elderly population and increase in prevalence of bone diseases.

According to WHO, the geriatric population is expected to increase to 16% of the global population by 2050 as compared to 7% of the global population that were above 65 years in 2000. The geriatric population are more prone to suffer from orthopaedic and cardiovascular related surgical procedures. The increase in geriatric population will increase the demand for these devices. According to a report by American Society of Plastic Surgeons, the number of minimally invasive procedures had increased by 2% in 2017 accounting for around 17 million as compared to 2016. Minimally invasive procedures require the use of devices that help in performing surgeries with precision. As powered surgical instruments are help surgeons manoeuvre the devices better and improve efficiency, the increase in these procedures help to increase the use of powered surgical procedures.

The rise in medical tourism in developing countries, increase in healthcare expenditure, rise in incidence of chronic diseases, and surgeons preference to use advanced powered surgical device further drives the growth of global powered surgical instruments market. However, the high cost of these devices and lack of skilled professionals are expected to hamper the market growth.

The Visiongain report analyst commented “The rise in the geriatric population, increase in incidence of chronic diseases, and rise in the number of surgical procedures conducted globally are the key factors boosting the growth of powered surgical instruments market. Moreover, the rise in medical tourism and market opportunities available in developing countries will help to further drive the market growth.”

The report covers a detailed competitive outlook that includes market share and company profiles of key players operating in the global market. Key players profiled in the report include Stryker Corporation, Zimmer Biomet, adeor Medical AG, AlloTech Co. Ltd., Conmed Corporation, Depuy Synthes, Medtronic plc, Smith & Nephew plc, B. Braun Melsungen AG, and MicroAire Surgical Instruments, LLC.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

23 April 2024

Read

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

Read

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

Read

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read